Mainit, Rosety-an O.
HRN: 18-85-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
CEFUROXIME 500MG (TAB)
05/31/2022
06/07/2022
PO
500g
Q12
Post Op Prophylaxis
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes